-
Lactate-GPR81/FARP1 Axis Enables Insulin-Independent Glucose
2026-07-20
The reference study uncovers a metabolite-driven signaling pathway—lactate-activated GPR81/FARP1—that facilitates glucose uptake in skeletal muscle independently of insulin. This finding advances our understanding of alternative glucose regulatory mechanisms and highlights new opportunities for metabolic disease research.
-
Imatinib (STI571): Protocols and Innovations in Cancer Biolo
2026-07-20
Imatinib (STI571) is a benchmark tyrosine kinase inhibitor transforming cancer and hematologic research through precision pathway modulation and robust synergy in combination assays. Discover optimized workflows, troubleshooting insights, and the latest synergy findings that elevate Imatinib's value in translational signal transduction research.
-
TCF25 Coordinates Lysosomal Cell Death Under Glucose Starvat
2026-07-19
Ren et al. (2025) identify TCF25 as a nutrient sensor that orchestrates metabolic adaptation and lysosome-dependent cell death during glucose starvation by enhancing lysosomal acidification and promoting ferritinophagy. This mechanistic insight bridges iron metabolism, autophagy, and cell fate, highlighting new therapeutic targets in metabolic and ischemic disorders.
-
H-89: cAMP-Dependent Protein Kinase Inhibitor in Osteogenesi
2026-07-18
H-89 empowers researchers to dissect cAMP-mediated signaling with high specificity, streamlining workflows in bone metabolism and cellular differentiation studies. Drawing on breakthrough findings from recent Wnt–O-GlcNAcylation research, this article delivers actionable protocols, troubleshooting guidance, and advanced applications for leveraging H-89 in modern experimental paradigms.
-
Purmorphamine as a Smoothened Agonist for Hedgehog Pathway S
2026-07-17
Purmorphamine is a synthetic Smoothened agonist widely used to modulate the Hedgehog signaling pathway in bone and sensory research. It robustly induces osteogenic differentiation and olfactory receptor expression via direct Smo activation. This dossier details its mechanism, evidence, workflows, and boundaries.
-
TGF-β Type I Inhibition: Unlocking EMT Control in Translatio
2026-07-17
Explore how LY364947, a potent TGF-β type I receptor kinase inhibitor from APExBIO, empowers translational researchers to dissect and modulate the EMT axis in cancer and fibrosis, with actionable guidance for protocol design and a strategic roadmap for preclinical innovation.
-
CCT007093 (SKU B3274): Reliable PPM1D Inhibitor for Cell Ass
2026-07-16
This article addresses practical laboratory challenges in PPM1D and p38 MAPK pathway research, highlighting how CCT007093 (SKU B3274) enables reproducible, data-driven results in cell viability and cytotoxicity assays. Scenario-driven Q&A blocks guide biomedical researchers and lab technicians through compound selection, optimization, and data interpretation, using evidence-backed recommendations and workflows.
-
BHPF as a Novel GPER Inhibitor: Insights from Neuroblastoma
2026-07-16
This study elucidates the molecular mechanism by which fluorene-9-bisphenol (BHPF), an environmental BPA substitute, directly inhibits the G protein-coupled estrogen receptor 1 (GPER/ GPR30) and induces apoptosis in human neuroblastoma cells. Combining molecular dynamics, mutagenesis, and cell-based assays, the findings clarify both BHPF’s binding mechanism and its distinctive antiestrogenic effects, with implications for toxicological risk assessment and estrogen signaling research.
-
Regorafenib Suppresses Melanoma via RRM2 and ERK/E2F3 Axis
2026-07-15
A recent iScience study demonstrates that Regorafenib (BAY 73-4506) inhibits melanoma progression by targeting RRM2 and disrupting ERK/E2F3 signaling. These findings clarify a new mechanistic pathway and offer practical direction for translational cancer biology research.
-
TAK-715: Next-Gen p38 MAPK Inhibitor for Inflammation Resear
2026-07-15
TAK-715 stands out as a selective p38 MAPK inhibitor, driving both precision and reproducibility in studies of inflammation and cytokine signaling. Backed by novel mechanistic insights, this compound empowers researchers to optimize workflows and overcome common pitfalls in chronic inflammatory disease models.
-
LDN-193189 as a Precision BMP Pathway Inhibitor in Corneal R
2026-07-14
Explore how LDN-193189, a potent ALK inhibitor, uniquely advances epithelial barrier function and corneal regenerative research. Discover protocol insights and practical guidance for leveraging this BMP signaling pathway inhibitor in translational epithelial biology.
-
Sphingosine-1-phosphate: Applied Protocols for Apoptosis & V
2026-07-14
Sphingosine-1-phosphate (S1P) enables precise modeling of apoptosis signaling and vascular maturation in cellular and in vivo studies. This article translates the latest S1P/S1PR3 pathway findings into actionable workflows, troubleshooting strategies, and advanced neuroprotection research using APExBIO’s B6707 S1P.
-
SR 11302: Precision AP-1 Inhibition for Tumor Immunomodulati
2026-07-13
Discover how SR 11302, a selective AP-1 transcription factor inhibitor, uniquely advances cancer immunomodulation research by enabling precise dissection of AP-1-driven tumor and immune mechanisms. This article provides a deeper, assay-focused analysis, linking the latest translational science with practical protocol guidance.
-
ARL4C Drives Synoviocyte Proliferation in Rheumatoid Arthrit
2026-07-13
This study uses multi-dimensional single-cell and bulk RNA sequencing to identify ARL4C as a key regulator of fibroblast-like synoviocyte (FLS) proliferation and macrophage polarization in rheumatoid arthritis (RA). The findings illuminate the mechanistic role of ARL4C in synovial inflammation and provide actionable insights for targeting FLSs in RA research and therapy.
-
Phosbind Acrylamide: Decoding Phosphorylation in Immune Sign
2026-07-12
Explore how Phosbind Acrylamide empowers advanced protein phosphorylation analysis, enabling precise, antibody-free detection in bacterial immune signaling research. This article reveals pivotal mechanistic insights and protocol optimizations not covered elsewhere.